Biosenta Inc.
ZRO
CNSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -33.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -33.33% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | 0.00% | -50.00% | |||
| SG&A Expenses | -14.22% | 28.05% | |||
| Depreciation & Amortization | 0.00% | -20.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.95% | 29.01% | |||
| Operating Income | 15.97% | -29.18% | |||
| Income Before Tax | 8.47% | -12.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.47% | -12.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.47% | -12.87% | |||
| EBIT | 15.97% | -29.18% | |||
| EBITDA | 15.96% | -29.19% | |||
| EPS Basic | 11.11% | -11.63% | |||
| Normalized Basic EPS | 11.11% | -11.11% | |||
| EPS Diluted | 11.11% | -11.63% | |||
| Normalized Diluted EPS | 11.11% | -11.11% | |||
| Average Basic Shares Outstanding | 2.52% | 1.51% | |||
| Average Diluted Shares Outstanding | 2.52% | 1.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||